June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus
May 24, 2024, 14:27

First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:

“First-line mFOLFIRINOX for GI high-grade neuroendocrine neoplasms?

  • ORR: 77% (complete response: 3%; partial response: 74%)
  • mPFS: 12 months
  • mOS: 20.6 months

Retrospective, n=35.

Prospective clinical trials are needed, may be considered in patients with high tumor burden and who can tolerate.”

 

Read further.
Source: Erman Akkus/X